HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thomas M Kündig Selected Research

Imiquimod (Aldara)

10/2021IL-12 regulates type 3 immunity through interfollicular keratinocytes in psoriasiform inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Thomas M Kündig Research Topics

Disease

32Hypersensitivity (Allergy)
01/2022 - 03/2002
13Neoplasms (Cancer)
01/2022 - 06/2005
8Inflammation (Inflammations)
01/2022 - 06/2007
7Infections
01/2022 - 03/2002
6Anaphylaxis (Anaphylactic Shock)
01/2020 - 12/2005
3Pruritus (Itching)
10/2021 - 12/2011
3Insect Bites and Stings (Insect Bite)
01/2020 - 10/2018
3Eczema
01/2015 - 11/2009
3Asthma (Bronchial Asthma)
06/2011 - 12/2006
2Lymphoma (Lymphomas)
01/2022 - 07/2021
2Bites and Stings (Sting)
01/2022 - 01/2013
2Psoriasis (Pustulosis Palmaris et Plantaris)
10/2021 - 06/2007
2Alzheimer Disease (Alzheimer's Disease)
01/2018 - 01/2013
2Rheumatoid Arthritis
01/2018 - 06/2007
2Allergic Rhinitis
01/2015 - 08/2014
2Contact Dermatitis (Eczema, Contact)
06/2010 - 03/2002
1Bacterial Infections (Bacterial Infection)
01/2022
1Leukemia
01/2022
1Eosinophilia
10/2021
1T-Cell Lymphoma (Lymphoma, T Cell)
07/2021
1Peanut Hypersensitivity (Peanut Allergy)
01/2020
1Chronic Disease (Chronic Diseases)
10/2018
1Colonic Neoplasms (Colon Cancer)
01/2018
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2018
1Mitochondrial Diseases (Mitochondrial Disease)
01/2018
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2018
1Colitis
01/2018
1Cowpox
10/2014
1Food Hypersensitivity (Food Allergy)
01/2014
1Disease Progression
03/2013
1Atherosclerosis
03/2013
1Mycosis Fungoides
02/2013
1Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
02/2013

Drug/Important Bio-Agent (IBA)

22AllergensIBA
10/2021 - 12/2005
15VaccinesIBA
01/2022 - 07/2004
11Immunoglobulin E (IgE)IBA
01/2022 - 11/2008
5AntigensIBA
01/2022 - 10/2009
4Immunoglobulin G (IgG)IBA
01/2022 - 12/2005
4CytokinesIBA
10/2021 - 06/2007
3AntibodiesIBA
01/2022 - 08/2010
3Interleukin-5 (Interleukin 5)IBA
10/2021 - 10/2018
3DNA (Deoxyribonucleic Acid)IBA
01/2015 - 04/2009
2Pharmaceutical PreparationsIBA
01/2022 - 01/2012
2Proteins (Proteins, Gene)FDA Link
01/2022 - 06/2007
2Bee Venoms (Bee Venom)IBA
01/2022 - 01/2013
2Messenger RNA (mRNA)IBA
07/2021 - 01/2021
2AluminumIBA
01/2020 - 03/2018
2Neutralizing AntibodiesIBA
01/2020 - 03/2013
2SaltsIBA
01/2020 - 03/2018
2InterleukinsIBA
01/2020 - 03/2013
2Clemastine (Clemastine Fumarate)FDA LinkGeneric
02/2013 - 12/2011
2Histamine Antagonists (Antihistamines)IBA
02/2013 - 12/2011
2Arthropod VenomsIBA
01/2013 - 12/2006
2CPG-oligonucleotideIBA
11/2012 - 06/2005
2OligonucleotidesIBA
11/2012 - 03/2002
2Peptides (Polypeptides)IBA
06/2007 - 03/2002
1Pentostatin (Nipent)FDA LinkGeneric
01/2022
1Immune Checkpoint InhibitorsIBA
01/2022
1Toll-Like Receptor 3IBA
01/2022
1Interferon Type IIBA
01/2022
1Adenosine DeaminaseIBA
01/2022
1Interleukin-12 (IL 12)IBA
10/2021
1Interleukin-23 Subunit p19IBA
10/2021
1Imiquimod (Aldara)FDA LinkGeneric
10/2021
1RNA (Ribonucleic Acid)IBA
10/2021
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
07/2021
1Therapeutic UsesIBA
07/2021
1BNT162 VaccineIBA
01/2021
1COVID-19 VaccinesIBA
01/2021
1Histocompatibility Antigens Class IIBA
01/2020
1monophosphoryl lipid AIBA
01/2020
1hypoxanthine arabinoside (ara-H)IBA
01/2020
1AutoantibodiesIBA
10/2018
1Immunologic Adjuvants (Immunologic Adjuvant)IBA
03/2018
1Mitochondrial Proteins (Mitochondrial Protein)IBA
01/2018
1Amyloid (Amyloid Fibrils)IBA
01/2018
1Non-Receptor Type 2 Protein Tyrosine PhosphataseIBA
01/2018
1InflammasomesIBA
01/2018
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2018
1aluminum sulfate (alum)IBA
01/2018
1Interleukin-2 (IL2)IBA
07/2015
1Photosensitizing Agents (Photosensitizers)IBA
07/2015
1Apolipoproteins E (ApoE)IBA
03/2013
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
03/2013
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
03/2013
1Transcription Factors (Transcription Factor)IBA
02/2013
1desloratadine (Aerius)FDA LinkGeneric
02/2013
1Complement System Proteins (Complement)IBA
02/2013
1STAT Transcription FactorsIBA
02/2013
1Epinephrine (Adrenaline)FDA LinkGeneric
01/2013
1Wasp Venoms (Venom, Wasp)IBA
01/2013
1Macrophage Colony-Stimulating FactorIBA
12/2012
1MART-1 AntigenIBA
11/2012
1LigandsIBA
11/2012

Therapy/Procedure

19Immunotherapy
10/2021 - 12/2006
6Therapeutics
01/2022 - 06/2007
2Drug Therapy (Chemotherapy)
01/2020 - 02/2013
2Injections
05/2012 - 11/2009
1Microspheres (Microsphere)
10/2021
1Duration of Therapy
02/2016